188 related articles for article (PubMed ID: 12771561)
1. Performance indicators of organized cervical screening in Romagna (Italy).
Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
[TBL] [Abstract][Full Text] [Related]
2. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
3. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytologic screening results of the cervix.
Yalti S; Gürbüz B; Bilgiç R; Cakar Y; Eren S
Int J Gynecol Cancer; 2005; 15(2):292-4. PubMed ID: 15823114
[TBL] [Abstract][Full Text] [Related]
5. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
6. [ASCUS in screening].
Caprara L; Monari F; De Bianchi PS; Amadori A; Bondi A
Pathologica; 2001 Dec; 93(6):645-50. PubMed ID: 11785115
[TBL] [Abstract][Full Text] [Related]
7. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
8. The cancer registry in the monitoring of cervical screening practice: the neglected value of the Pap smear in patients diagnosed with CIN3 on biopsy.
Serafini M; Bucchi L; Falcini F; Cordaro C; Montanari E; Amadori A; Amadori D
Eur J Cancer Prev; 1998 Feb; 7(1):45-9. PubMed ID: 9511850
[TBL] [Abstract][Full Text] [Related]
9. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
12. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
13. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
Mannino JR
J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
[TBL] [Abstract][Full Text] [Related]
14. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
Cox JT; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
[TBL] [Abstract][Full Text] [Related]
15. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
16. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations.
Cardin VA; Grimes RM; Jiang ZD; Pomeroy N; Harrell L; Cano P
Public Health Rep; 2001; 116(6):608-16. PubMed ID: 12196621
[TBL] [Abstract][Full Text] [Related]
17. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
Sherman ME; Wang SS; Tarone R; Rich L; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):372-9. PubMed ID: 12692113
[TBL] [Abstract][Full Text] [Related]
19. The triage of squamous cell abnormalities of cervical cytology by human papilloma virus screening.
Ozsaran AA; Dikmen Y; Akercan F; Zekioglu O; Terek MC; Mgoyi L; Altuglu I
Eur J Gynaecol Oncol; 2003; 24(6):535-8. PubMed ID: 14658597
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
